H.R. 1424 · 114th Congress
Infection Reduction Labeling Act
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 114th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
R
LattaSponsor18 cosponsors · 4 D, 14 R
R
Murphy
JY
D
Yarmuth
PP
D
Pierluisi
MB
R
Bost
EE
D
Esty
DB
R
Black
BS
R
Shuster
SF
R
Fincher
RB
R
Blum
RC
R
Crawford
LW
R
Westmoreland
BD
R
Dold
PM
R
McHenry
PR
R
Roskam
MB
R
Brooks
BB
D
Boyle
DJ
R
Joyce
RD
R
Davis2 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
This bill amends the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) to authorize solid antimicrobial copper alloys, and products made from such alloys, to be marketed, distributed, or sold with labels about their infection reduction and control efficacy if the antimicrobial claims made on the label are consistent with the results of…
What it does: CRS summary · Introduced in House · Mar 18, 2015
Infection Reduction Labeling Act
This bill amends the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) to authorize solid antimicrobial copper alloys, and products made from such alloys, to be marketed, distributed, or sold with labels about their infection reduction and control efficacy if the antimicrobial claims made on the label are consistent with the results of federally-funded clinical trials finding: (1) greater than 25% reductions in infection rate or 50% reductions in microbial burden, or (2) statistically significant reductions in infection rate or microbial burden.
Requirements to submit or review efficacy data related to the antimicrobial claims are waived for these alloys if the claims are consistent with the results of the trials.
An alternative process to modify the labeling of an alloy may be used in lieu of the current process.
This bill amends the Federal Food, Drug, and Cosmetic Act to exclude a product that is made from the alloy and has the antimicrobial labeling from regulation and treatment as a drug or device.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Infection Reduction Labeling Act
Latest action (Apr 8, 2015): Referred to the Subcommittee on Biotechnology, Horticulture, and Research.
Policy area: Environmental Protection · Origin: House · Introduced: Mar 18, 2015
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.